Table 2.
Kaplan-Meier estimates for OS, LPFS, RPFS, and DPFS.
| Kaplan Meier-Estimates | All cohort |
|---|---|
| Median follow-up | |
| From diagnosis—months (IQR) | 12.3 (6.0–23.3) |
| Median survival | |
| Median survival—months (95% I) | 40 (12.3–16.5) |
| 12-months | 60.0% |
| 24-months | 27.0 % |
| Local control from SBRT | |
| Median time to LF (95%CI) | Median not reached (20.8–infinity) |
| 12-months | 72% |
| 24-months | 63% |
| Regional control from SBRT | |
| Median time to RF (95% CI) | Median not reached (N/A) |
| 12-months | 92% |
| 24-months | 92% |
| Distant metastases free survival | |
| Median time to DM (95% CI) | 23.1 (14.4–33.6) |
| 12-months | 62% |
| 24-months | 47% |